Hillstream BioPharma (HILS) Competitors $1.78 -0.16 (-8.26%) As of 07/1/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock HILS vs. PROC, OPTN, VIRI, WHWK, VHAQ, PYRGF, OSTX, AADI, NBRV, and ATNMShould you be buying Hillstream BioPharma stock or one of its competitors? The main competitors of Hillstream BioPharma include Procaps Group (PROC), OptiNose (OPTN), Virios Therapeutics (VIRI), Whitehawk Therapeutics (WHWK), Viveon Health Acquisition (VHAQ), PyroGenesis Canada (PYRGF), OS Therapies (OSTX), Aadi Bioscience (AADI), Nabriva Therapeutics (NBRV), and Actinium Pharmaceuticals (ATNM). Hillstream BioPharma vs. Its Competitors Procaps Group OptiNose Virios Therapeutics Whitehawk Therapeutics Viveon Health Acquisition PyroGenesis Canada OS Therapies Aadi Bioscience Nabriva Therapeutics Actinium Pharmaceuticals Procaps Group (NASDAQ:PROC) and Hillstream BioPharma (NASDAQ:HILS) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, institutional ownership, earnings, analyst recommendations, valuation and dividends. Does the media favor PROC or HILS? In the previous week, Procaps Group's average media sentiment score of 0.00 equaled Hillstream BioPharma'saverage media sentiment score. Company Overall Sentiment Procaps Group Neutral Hillstream BioPharma Neutral Which has stronger valuation & earnings, PROC or HILS? Procaps Group has higher revenue and earnings than Hillstream BioPharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProcaps Group$409.92M0.26$42.54MN/AN/AHillstream BioPharmaN/AN/A-$8.47M-$0.72-2.47 Is PROC or HILS more profitable? Procaps Group's return on equity of 0.00% beat Hillstream BioPharma's return on equity.Company Net Margins Return on Equity Return on Assets Procaps GroupN/A N/A N/A Hillstream BioPharma N/A -188.44%-149.61% Do institutionals and insiders hold more shares of PROC or HILS? 13.4% of Hillstream BioPharma shares are held by institutional investors. 19.9% of Procaps Group shares are held by insiders. Comparatively, 30.2% of Hillstream BioPharma shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has more risk and volatility, PROC or HILS? Procaps Group has a beta of -0.05, meaning that its stock price is 105% less volatile than the S&P 500. Comparatively, Hillstream BioPharma has a beta of 3.08, meaning that its stock price is 208% more volatile than the S&P 500. SummaryProcaps Group beats Hillstream BioPharma on 4 of the 7 factors compared between the two stocks. Get Hillstream BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for HILS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HILS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HILS vs. The Competition Export to ExcelMetricHillstream BioPharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$31.33M$782.83M$5.50B$9.00BDividend YieldN/A4.84%5.39%4.10%P/E Ratio-2.471.3026.5720.02Price / SalesN/A219.25415.46120.95Price / CashN/A23.4436.1356.90Price / Book3.715.998.065.50Net Income-$8.47M-$27.64M$3.15B$248.50M7 Day Performance7.23%0.00%1.72%2.61%1 Month Performance22.57%6.61%3.92%5.42%1 Year Performance-46.22%8.25%35.02%20.76% Hillstream BioPharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HILSHillstream BioPharmaN/A$1.78-8.3%N/A-48.4%$31.33MN/A-2.471PROCProcaps GroupN/A$0.95-40.3%N/A-62.0%$107.18M$409.92M0.004,900Gap DownHigh Trading VolumeOPTNOptiNose0.6866 of 5 stars$9.60flat$9.00-6.3%N/A$97.22M$81.86M-2.29190VIRIVirios TherapeuticsN/A$4.77+1.3%$5.00+4.8%+2,015.4%$91.86MN/A-17.675WHWKWhitehawk TherapeuticsN/A$1.86-0.5%N/AN/A$88.09M$25.98M0.0040VHAQViveon Health AcquisitionN/A$11.00flatN/AN/A$62.26MN/A0.002High Trading VolumePYRGFPyroGenesis Canada0.0899 of 5 stars$0.33+0.9%N/A-35.5%$62.17M$9.14M-5.5590News CoverageGap UpOSTXOS Therapies2.4423 of 5 stars$1.93+2.7%$18.00+832.6%N/A$54.23MN/A-2.24N/ANews CoverageAnalyst ForecastAADIAadi Bioscience0.6022 of 5 stars$1.87-3.1%$1.67-10.9%+40.9%$46.18M$25.07M-0.8240NBRVNabriva TherapeuticsN/AN/AN/AN/A$45.46M$35.59M0.0070ATNMActinium Pharmaceuticals2.3672 of 5 stars$1.35-3.6%$4.00+196.3%N/A$42.12M$81K-0.9730News Coverage Related Companies and Tools Related Companies PROC Competitors OPTN Competitors VIRI Competitors WHWK Competitors VHAQ Competitors PYRGF Competitors OSTX Competitors AADI Competitors NBRV Competitors ATNM Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HILS) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hillstream BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hillstream BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HILS Stock Alerts